Brief: Novus Therapeutics Reports Q3 2020 Financial Results
Nov 16 (Reuters) - Novus Therapeutics Inc NVUS.O :
* NOVUS THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL
RESULTS
* Q3 LOSS PER SHARE $5.51
* Q3 EARNINGS PER SHARE ESTIMATE $-1.75 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nBw38zqDNa
Further company coverage: NVUS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial